Physician profile
Joseph J Wolcott
NPI 1114119872
$38,261.36
in general payments reported to CMS, 2019-2025
22 companies · $5,263 in 2025
The $5,263 reported for 2025 was more than what 92% of Undersea and Hyperbaric Medicine (Preventive Medicine) providers received nationally (typical 2025 total: $210).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,476 · 2020: $5,477 · 2021: $5,685 · 2022: $5,732 · 2023: $5,421 · 2024: $5,207 · 2025: $5,263.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $14K · Food and Beverage: $1,491.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $14,400.00 |
| Food and Beverage | $1,490.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $33,645.43 | 2019-2025 | Venacure 1470 Pro, Venacure 1470 Pro |
| Smith+Nephew, INC. | $1,012.01 | 2019-2024 | Grafix Pl |
| Tactile Systems Technology INC | $940.22 | 2019-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Organogenesis INC. | $801.84 | 2019-2023 | Puraply |
| Boston Scientific Corporation | $402.53 | 2023-2025 | Varithena Administration Pack |
| Abbvie INC. | $378.99 | 2021-2023 | Teflaro, Dalvance |
| Solventum Corporation | $228.59 | 2024-2025 | Activ.A.C. |
| Nabriva Therapeutics, Plc | $212.43 | 2021-2022 | |
| Melinta Therapeutics, LLC | $211.27 | 2019-2025 | Kimyrsa |
| Acera Surgical, INC. | $94.71 | 2022 | |
| Paratek Pharmaceuticals, INC. | $79.16 | 2024 | Nuzyra |
| Allergan, INC. | $64.32 | 2019-2020 | |
| Convatec INC. | $52.72 | 2019-2021 | |
| Sanara Medtech INC. | $30.52 | 2021 | |
| Globus Medical, INC. | $19.46 | 2025 | Senza |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $17.87 | 2023 | Supera |
| Merck Sharp & Dohme LLC | $13.61 | 2019 | |
| Hartmann USA, INC. | $13.36 | 2021 | |
| Coloplast Corp | $13.01 | 2023 | Speedicath |
| Osiris Therapeutics INC. | $12.96 | 2019 | |
| Aroa Biosurgery Incorporated | $12.47 | 2020 | |
| Medela LLC | $3.88 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Wolcott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.